Concepedia

Hannah L. Archibald

HL

Statistics

Publications

6

Citations

1.3K

H-Index

6

Active since

2016

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Broad Institute

Rutgers, The State University of New Jersey

Technion – Israel Institute of Technology

Hannah L. Archibald is an author at Massachusetts General Hospital specializing in tumor biology, cell biology, and cancer research.

Top concepts

Publications per year

2016–2023

6

Publications

6

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

Aaron N. Hata, Matthew J. Niederst, Hannah L. Archibald et al. · Nature Medicine · 2016 · 968 citations · Full text

, , +7

Therapy-induced APOBEC3A drives evolution of persistent cancer cells

Hideko Isozaki, Ramin Sakhtemani, Ammal Abbasi et al. · Nature · 2023 · 130 citations · Full text

, , +4

Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM

Kyung-A Song, Matthew J. Niederst, Timothy L. Lochmann et al. · Clinical Cancer Research · 2017 · 93 citations · Full text

Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in <i>KRAS</i> -Mutant Non–Small Cell Lung Cancer

Varuna Nangia, Faria M. Siddiqui, Sean Caenepeel et al. · Cancer Discovery · 2018 · 91 citations

Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers

Aaron N. Hata, Steve Rowley, Hannah L. Archibald et al. · Oncogene · 2017 · 34 citations · Full text

1–5 of 6